IN2015DN00085A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN00085A IN2015DN00085A IN85DEN2015A IN2015DN00085A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A IN 85DEN2015 A IN85DEN2015 A IN 85DEN2015A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A
- Authority
- IN
- India
- Prior art keywords
- compounds
- preparation
- general formula
- methods
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12175640 | 2012-07-10 | ||
EP12185590 | 2012-09-24 | ||
EP13170585 | 2013-06-05 | ||
PCT/EP2013/064017 WO2014009219A1 (en) | 2012-07-10 | 2013-07-03 | Method for preparing substituted triazolopyridines |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN00085A true IN2015DN00085A (de) | 2015-05-29 |
Family
ID=48793197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN85DEN2015 IN2015DN00085A (de) | 2012-07-10 | 2013-07-03 |
Country Status (24)
Country | Link |
---|---|
US (1) | US9388177B2 (de) |
EP (1) | EP2872506A1 (de) |
JP (1) | JP6238979B2 (de) |
KR (1) | KR20150040845A (de) |
CN (1) | CN104603136B (de) |
AP (1) | AP3778A (de) |
AU (1) | AU2013289381A1 (de) |
BR (1) | BR112015000308A2 (de) |
CA (1) | CA2878481A1 (de) |
CL (1) | CL2015000038A1 (de) |
CO (1) | CO7160002A2 (de) |
CR (1) | CR20150006A (de) |
DO (1) | DOP2015000007A (de) |
EA (1) | EA027544B1 (de) |
HK (1) | HK1206731A1 (de) |
IL (1) | IL236265A (de) |
IN (1) | IN2015DN00085A (de) |
MX (1) | MX2015000348A (de) |
NZ (1) | NZ703020A (de) |
PE (1) | PE20150354A1 (de) |
PH (1) | PH12015500061A1 (de) |
SG (1) | SG11201408419QA (de) |
TN (1) | TN2015000008A1 (de) |
WO (1) | WO2014009219A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2914521A1 (en) * | 2013-06-07 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Substituted triazolopyridines having activity as mps-1 inhibitors |
AP2015008898A0 (en) * | 2013-06-11 | 2015-12-31 | Bayer Pharma AG | Prodrug derivatives of substituted triazolopyridines |
CA2914742A1 (en) | 2013-06-11 | 2014-12-18 | Bayer Pharma Aktiengesellschaft | Handovers with co-operating cells configured to provide coordinated multi-point transmission/reception |
PL3283642T3 (pl) | 2015-04-17 | 2024-04-22 | Crossfire Oncology Holding B.V. | Biomarkery prognostyczne dla chemioterapii inhibitorem TTK |
TW201800408A (zh) | 2016-06-15 | 2018-01-01 | 拜耳製藥公司 | Mps-1抑制劑 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1438973A4 (de) * | 2001-10-05 | 2005-07-13 | Ono Pharmaceutical Co | Mittel zur behandlung von stressbedingten erkrankungen mit mitochondrien-benzodiazepin-rezeptorantagonisten |
US20060074102A1 (en) * | 2004-05-14 | 2006-04-06 | Kevin Cusack | Kinase inhibitors as therapeutic agents |
UA89503C2 (uk) * | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Заміщені похідні аніліну |
MX2007004179A (es) * | 2004-10-07 | 2007-06-07 | Warner Lambert Co | Derivados de triazolpiridina como agentes antibacterianos. |
US20060194823A1 (en) * | 2004-12-22 | 2006-08-31 | Georg Kettschau | Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof |
MX2008015747A (es) * | 2006-06-06 | 2008-12-19 | Schering Corp | Imidazopirazinas como inhibidores de la proteina quinasa. |
EP1870416A1 (de) * | 2006-06-21 | 2007-12-26 | Bayer Schering Pharma Aktiengesellschaft | Sulfonamidmakrozyklen als Tie2-Inhibitoren |
CN103641829A (zh) | 2006-08-30 | 2014-03-19 | 塞尔佐姆有限公司 | 作为激酶抑制剂的三唑衍生物 |
JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
AU2008277628B2 (en) | 2007-07-18 | 2012-03-15 | Novartis Ag | Bicyclic heteroaryl compounds and their use as kinase inhibitors |
BRPI0815709A2 (pt) | 2007-08-23 | 2017-06-13 | Astrazeneca Ab | composro, composição farmacêutica, e, uso de um composto. |
CA2691448A1 (en) | 2007-08-31 | 2009-03-05 | Dominique Swinnen | Triazolopyridine compounds and their use as ask inhibitors |
GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
GB0724342D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
US8530689B2 (en) * | 2008-05-05 | 2013-09-10 | The Trustees Of The University Of Pennsylvania | Processes for the preparation of biphenyl compounds |
EP2303890A4 (de) * | 2008-06-19 | 2012-04-11 | Progenics Pharm Inc | Inhibitoren von phosphatidylinosit-3-kinase |
CA2751517A1 (en) | 2009-02-13 | 2010-08-19 | Fovea Pharmaceuticals | [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors |
CN102413831B (zh) | 2009-04-29 | 2014-06-04 | 拜耳知识产权有限责任公司 | 取代的咪唑并喹喔啉 |
TWI500614B (zh) * | 2009-06-05 | 2015-09-21 | Cephalon Inc | 1,2,4-三唑並〔1,5a〕吡啶衍生物之製備和用途 |
WO2010141360A1 (en) * | 2009-06-05 | 2010-12-09 | Merck Sharp & Dohme Corp. | Biaryl benzotriazole derivatives |
CA2772790C (en) | 2009-09-04 | 2017-06-27 | Benjamin Bader | Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
EP2343294A1 (de) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Substituierte Triazolopyridine |
EP2343297A1 (de) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridine |
EP2343295A1 (de) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridin-Derivate |
UY33452A (es) * | 2010-06-16 | 2012-01-31 | Bayer Schering Pharma Ag | Triazolopiridinas sustituidas |
WO2012044567A2 (en) * | 2010-09-30 | 2012-04-05 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
PT2699575E (pt) * | 2011-04-21 | 2015-07-29 | Bayer Ip Gmbh | Triazolopiridinas |
WO2012160029A1 (en) * | 2011-05-23 | 2012-11-29 | Bayer Intellectual Property Gmbh | Substituted triazolopyridines |
UA112096C2 (uk) * | 2011-12-12 | 2016-07-25 | Байєр Інтеллектуал Проперті Гмбх | Заміщені триазолопіридини та їх застосування як інгібіторів ttk |
-
2013
- 2013-07-03 WO PCT/EP2013/064017 patent/WO2014009219A1/en active Application Filing
- 2013-07-03 JP JP2015520907A patent/JP6238979B2/ja not_active Expired - Fee Related
- 2013-07-03 US US14/414,164 patent/US9388177B2/en not_active Expired - Fee Related
- 2013-07-03 CA CA2878481A patent/CA2878481A1/en not_active Abandoned
- 2013-07-03 CN CN201380045913.9A patent/CN104603136B/zh not_active Expired - Fee Related
- 2013-07-03 EP EP13737181.1A patent/EP2872506A1/de not_active Withdrawn
- 2013-07-03 SG SG11201408419QA patent/SG11201408419QA/en unknown
- 2013-07-03 NZ NZ703020A patent/NZ703020A/en not_active IP Right Cessation
- 2013-07-03 BR BR112015000308A patent/BR112015000308A2/pt not_active IP Right Cessation
- 2013-07-03 PE PE2015000017A patent/PE20150354A1/es not_active Application Discontinuation
- 2013-07-03 EA EA201590116A patent/EA027544B1/ru not_active IP Right Cessation
- 2013-07-03 AP AP2014008177A patent/AP3778A/en active
- 2013-07-03 IN IN85DEN2015 patent/IN2015DN00085A/en unknown
- 2013-07-03 MX MX2015000348A patent/MX2015000348A/es unknown
- 2013-07-03 AU AU2013289381A patent/AU2013289381A1/en not_active Abandoned
- 2013-07-03 KR KR20157000338A patent/KR20150040845A/ko not_active Application Discontinuation
-
2014
- 2014-12-15 IL IL236265A patent/IL236265A/en not_active IP Right Cessation
-
2015
- 2015-01-07 TN TNP2015000008A patent/TN2015000008A1/fr unknown
- 2015-01-08 CL CL2015000038A patent/CL2015000038A1/es unknown
- 2015-01-09 CR CR20150006A patent/CR20150006A/es unknown
- 2015-01-09 CO CO15004251A patent/CO7160002A2/es unknown
- 2015-01-09 DO DO2015000007A patent/DOP2015000007A/es unknown
- 2015-01-09 PH PH12015500061A patent/PH12015500061A1/en unknown
- 2015-07-29 HK HK15107242.4A patent/HK1206731A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US9388177B2 (en) | 2016-07-12 |
SG11201408419QA (en) | 2015-01-29 |
EA201590116A1 (ru) | 2015-07-30 |
TN2015000008A1 (en) | 2016-06-29 |
DOP2015000007A (es) | 2015-02-15 |
HK1206731A1 (en) | 2016-01-15 |
CO7160002A2 (es) | 2015-01-15 |
IL236265A0 (en) | 2015-02-26 |
PH12015500061A1 (en) | 2015-03-02 |
US20150148542A1 (en) | 2015-05-28 |
AP3778A (en) | 2016-08-31 |
NZ703020A (en) | 2017-08-25 |
BR112015000308A2 (pt) | 2017-06-27 |
KR20150040845A (ko) | 2015-04-15 |
IL236265A (en) | 2017-07-31 |
CR20150006A (es) | 2015-02-16 |
AP2014008177A0 (en) | 2014-12-31 |
AU2013289381A1 (en) | 2015-01-22 |
CN104603136B (zh) | 2017-06-27 |
WO2014009219A1 (en) | 2014-01-16 |
CA2878481A1 (en) | 2014-01-16 |
CL2015000038A1 (es) | 2015-03-13 |
EA027544B1 (ru) | 2017-08-31 |
EP2872506A1 (de) | 2015-05-20 |
JP6238979B2 (ja) | 2017-11-29 |
JP2015523372A (ja) | 2015-08-13 |
MX2015000348A (es) | 2015-04-14 |
CN104603136A (zh) | 2015-05-06 |
PE20150354A1 (es) | 2015-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ743274A (en) | Substituted tricyclic compounds as fgfr inhibitors | |
PH12015502839A1 (en) | Antiviral compounds | |
ZA201500316B (en) | Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof | |
IL235944A0 (en) | β-lactamase inhibitor compounds, preparations containing them, methods for their preparation and their uses | |
AU2012213775A8 (en) | 7-azaindole derivatives | |
NZ704662A (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
IN2014MN02598A (de) | ||
MX352881B (es) | Metodos y compuestos utiles en la sintesis de antagonistas del receptor de orexina 2. | |
EA201590887A1 (ru) | Композиция | |
SG195086A1 (en) | Compounds containing hydrido-tricyano-borate anions | |
IN2014DN06104A (de) | ||
JO3154B1 (ar) | عوامل مضادة لـ trpv4 | |
NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
PH12015501175A1 (en) | Substituted pyridopyrazines as syk inhibitors | |
MX345926B (es) | Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas. | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
GEP201706626B (en) | Synthesis of (s)-nifuratel | |
PH12015500061A1 (en) | Method for preparing substituted triazolopyridines | |
MX2012010127A (es) | Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos. | |
GB201107985D0 (en) | Process | |
MX347541B (es) | Analogos de acido sialico. | |
UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
AU2012248013B2 (en) | Intermediate for synthesizing caspofungin and preparation method therefor | |
IN2014DN10135A (de) | ||
MX2015005510A (es) | Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. |